News

The World Federation of Neurosurgical Societies Has Named a Chennai Startup as Its First-Ever Industry Innovation Partner — Time Medical International Ventures and Intraoperative MRI

By Mustafa Shariff, Editor in Chief · May 25, 2026 · 2 min read

Mustafa Shariff, Editor in Chief — The World Federation of Neurosurgical Societies Has Named a Chennai Startup as Its First-Ever Industry Innovation Partner — Time Medical International Ventures and Intraoperative MRI

Summary

WFNS Names Chennai's Time Medical Ventures as Its First Industry Innovation Partner: What Intraoperative MRI Means for Neurosurgery
The WFNS has named Time Medical International Ventures as its first-ever industry partner in its Innovation & Technology Committee. Here is the full story of the Chennai startup and what intraoperative MRI means for neurosurgery.

"This collaboration will help champion the development and global dissemination of cutting-edge neurosurgical solutions, facilitate knowledge exchange between leading neurosurgeons and industry experts, and support training and technology transfer initiatives in emerging markets."

The World Federation of Neurosurgical Societies — the global umbrella organisation representing over 45,000 neurosurgeons across more than 130 member societies worldwide — has taken an unprecedented step in its institutional history: for the first time, its Innovation & Technology Committee has formally welcomed an industry partner into its innovation ecosystem. That partner is Time Medical International Ventures, a Chennai-based startup recognised for its contributions in advanced medical imaging and neurosurgical technologies.

The WFNS Innovation & Technology Committee was established to accelerate the development and dissemination of cutting-edge neurosurgical technologies globally — including supporting training and capacity-building initiatives and facilitating meaningful collaboration between clinicians and industry innovators. The decision to formalise a partnership with Time Medical International Ventures reflects a specific recognition: the company has built capabilities in neurosurgical imaging technology that the global neurosurgical community considers worthy of systematic collaboration and global dissemination.

What Time Medical International Ventures Builds

Time Medical International Ventures operates at the intersection of magnetic resonance imaging technology and surgical workflow design — a technically demanding space that requires deep expertise in both MRI physics and the operational requirements of neurosurgical theatre environments. The company's flagship capability is the development and deployment of single-room intraoperative MRI operation suites — dedicated operating theatre environments where MRI scanning is integrated directly into the surgical workflow.

Intraoperative MRI is a clinical capability that addresses one of the most significant limitations of conventional neurosurgery: the inability to visualise the surgical field in real time with the quality and soft-tissue contrast that MRI provides. Conventional neurosurgery is performed using pre-operative MRI scans that show the anatomy and pathology before surgery begins — but once surgery starts, the brain's position changes, tumour resection alters the field, and the pre-operative imaging becomes increasingly inaccurate as a guide. The result is that surgeons may leave residual tumour tissue behind in cases where complete resection is achievable, or — in avoiding residual tumour — encroach on functionally critical brain areas.

With intraoperative MRI, the surgeon can pause the operation at any point, acquire a new MRI scan within the operating environment, and see exactly what has been achieved and what remains — making real-time decisions about whether to continue resection, adjust surgical trajectory, or close. Multiple studies have demonstrated that intraoperative MRI guidance significantly improves the rate of complete tumour resection in neurosurgical oncology — the single most important predictor of patient survival in most brain tumour categories.

The Other Technologies

Beyond intraoperative MRI suites, Time Medical International Ventures has developed Exoscope and visualisation technologies — next-generation surgical visualisation systems that provide neurosurgeons with high-definition, magnified views of the operative field through external optics rather than conventional operating microscopes. Exoscopes offer ergonomic advantages for surgeons, shared visualisation capability for surgical teams, and integration with digital recording and AI-assisted image enhancement. The company has also developed specialised MRI solutions for brain aneurysm and intracranial atherosclerotic disease (ICAD) screening — diagnostic imaging applications that are particularly relevant for India's growing cerebrovascular disease burden.

The WFNS Partnership's Global Implications

Prof Dr Iype Cherian, Chairperson of the WFNS Innovation & Technology Committee, articulated the partnership's ambition: championing the development and global dissemination of cutting-edge neurosurgical solutions, facilitating knowledge exchange between leading neurosurgeons and industry experts, and supporting training and technology transfer initiatives in emerging markets. The emphasis on emerging markets is significant — the neurosurgical innovation that has historically been developed for and deployed in well-resourced healthcare systems in the US, Europe, and Japan is now beginning to be designed and adapted for the infrastructure realities of healthcare systems in South Asia, Africa, and Southeast Asia, where the majority of the world's neurosurgical burden occurs.

BHC Perspective

At Bengaluru Health Community, the WFNS-Time Medical partnership is a story about an Indian MedTech startup earning the recognition of the world's neurosurgical leadership through genuine technological capability — not through marketing or government connections, but through building intraoperative MRI suites and neurosurgical visualisation systems that the global neurosurgical community wants to adopt. For BHC founders building in medical imaging, surgical technology, or neurotech — this is the benchmark for what earning global institutional recognition looks like.

Frequently Asked Questions

Q: What did the WFNS announce?
A: The World Federation of Neurosurgical Societies — representing 45,000+ neurosurgeons across 130+ member societies — formally welcomed Chennai's Time Medical International Ventures as the first-ever industry partner in its Innovation & Technology Committee.

Q: What does Time Medical International Ventures build?
A: Single-room intraoperative MRI operation suites, Exoscope and surgical visualisation technologies, and specialised MRI solutions for brain aneurysm and ICAD screening — all focused on integrating advanced imaging into neurosurgical workflows.

Q: Why is intraoperative MRI clinically significant?
A: It allows surgeons to acquire real-time MRI images mid-surgery to assess tumour resection completeness — addressing the fact that pre-operative scans become inaccurate guides once surgery begins. Multiple studies show intraoperative MRI significantly improves complete tumour resection rates.